vs
Honest Company, Inc.（HNST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Honest Company, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$88.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -11.8%），Honest Company, Inc.自由现金流更多（$18.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.0%）
诚实公司（The Honest Company, Inc.）是总部位于美国洛杉矶的数字化原生消费品公司，由女演员杰西卡·阿尔芭与克里斯托弗·加维根、布莱恩·李共同创立。2021年该公司销售额达3.19亿美元，截至2022年2月估值约为5.5亿美元。现任首席执行官卡拉·贝尔农是美国上市企业中少有的非裔拉丁裔首席执行官。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HNST vs PBYI — 直观对比
营收规模更大
HNST
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出39.5%
-11.8%
自由现金流更多
HNST
多$3.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.0M | $75.5M |
| 净利润 | $-23.6M | — |
| 毛利率 | 15.7% | 69.3% |
| 营业利润率 | -27.5% | 22.7% |
| 净利率 | -26.8% | — |
| 营收同比 | -11.8% | 27.7% |
| 净利润同比 | -2813.2% | — |
| 每股收益（稀释后） | $-0.21 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HNSTPBYI
| Q4 25 | $88.0M | $75.5M | ||
| Q3 25 | $92.6M | $54.5M | ||
| Q2 25 | $93.5M | $52.4M | ||
| Q1 25 | $97.3M | $46.0M | ||
| Q4 24 | $99.8M | $59.1M | ||
| Q3 24 | $99.2M | $80.5M | ||
| Q2 24 | $93.0M | $47.1M | ||
| Q1 24 | $86.2M | $43.8M |
净利润HNSTPBYI
| Q4 25 | $-23.6M | — | ||
| Q3 25 | $758.0K | $8.8M | ||
| Q2 25 | $3.9M | $5.9M | ||
| Q1 25 | $3.3M | $3.0M | ||
| Q4 24 | $-809.0K | — | ||
| Q3 24 | $165.0K | $20.3M | ||
| Q2 24 | $-4.1M | $-4.5M | ||
| Q1 24 | $-1.4M | $-4.8M |
毛利率HNSTPBYI
| Q4 25 | 15.7% | 69.3% | ||
| Q3 25 | 37.3% | 77.7% | ||
| Q2 25 | 40.4% | 76.5% | ||
| Q1 25 | 38.7% | 77.1% | ||
| Q4 24 | 38.8% | 76.4% | ||
| Q3 24 | 38.7% | 63.9% | ||
| Q2 24 | 38.3% | 77.4% | ||
| Q1 24 | 37.0% | 75.5% |
营业利润率HNSTPBYI
| Q4 25 | -27.5% | 22.7% | ||
| Q3 25 | 0.3% | 17.6% | ||
| Q2 25 | 3.1% | 12.7% | ||
| Q1 25 | 2.6% | 8.7% | ||
| Q4 24 | -1.0% | 22.6% | ||
| Q3 24 | 0.1% | 27.4% | ||
| Q2 24 | -4.3% | -4.6% | ||
| Q1 24 | -1.5% | -5.3% |
净利率HNSTPBYI
| Q4 25 | -26.8% | — | ||
| Q3 25 | 0.8% | 16.2% | ||
| Q2 25 | 4.1% | 11.2% | ||
| Q1 25 | 3.3% | 6.5% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 0.2% | 25.2% | ||
| Q2 24 | -4.4% | -9.6% | ||
| Q1 24 | -1.6% | -11.0% |
每股收益（稀释后）HNSTPBYI
| Q4 25 | $-0.21 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $0.03 | $0.12 | ||
| Q1 25 | $0.03 | $0.06 | ||
| Q4 24 | $-0.01 | $0.40 | ||
| Q3 24 | $0.00 | $0.41 | ||
| Q2 24 | $-0.04 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $169.7M | $130.3M |
| 总资产 | $225.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HNSTPBYI
| Q4 25 | $89.6M | $97.5M | ||
| Q3 25 | $71.5M | $94.4M | ||
| Q2 25 | $72.1M | $96.0M | ||
| Q1 25 | $72.8M | $93.2M | ||
| Q4 24 | $75.4M | $101.0M | ||
| Q3 24 | $53.4M | $96.7M | ||
| Q2 24 | $36.6M | $96.8M | ||
| Q1 24 | $33.6M | $107.2M |
总债务HNSTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HNSTPBYI
| Q4 25 | $169.7M | $130.3M | ||
| Q3 25 | $190.2M | $115.3M | ||
| Q2 25 | $187.0M | $104.7M | ||
| Q1 25 | $180.4M | $97.1M | ||
| Q4 24 | $174.3M | $92.1M | ||
| Q3 24 | $133.9M | $71.1M | ||
| Q2 24 | $129.7M | $48.5M | ||
| Q1 24 | $124.8M | $51.0M |
总资产HNSTPBYI
| Q4 25 | $225.4M | $216.3M | ||
| Q3 25 | $241.5M | $202.9M | ||
| Q2 25 | $249.0M | $194.9M | ||
| Q1 25 | $265.3M | $196.2M | ||
| Q4 24 | $247.4M | $213.3M | ||
| Q3 24 | $209.2M | $220.7M | ||
| Q2 24 | $200.2M | $205.0M | ||
| Q1 24 | $198.1M | $214.1M |
负债/权益比HNSTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $18.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 20.5% | 19.1% |
| 资本支出强度资本支出/营收 | 1.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $13.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HNSTPBYI
| Q4 25 | $19.3M | $14.4M | ||
| Q3 25 | $-504.0K | $9.7M | ||
| Q2 25 | $-745.0K | $14.1M | ||
| Q1 25 | $-2.9M | $3.6M | ||
| Q4 24 | $-16.8M | $15.6M | ||
| Q3 24 | $15.1M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $336.0K | $11.2M |
自由现金流HNSTPBYI
| Q4 25 | $18.1M | $14.4M | ||
| Q3 25 | $-624.0K | $9.7M | ||
| Q2 25 | $-826.0K | $14.1M | ||
| Q1 25 | $-3.0M | $3.6M | ||
| Q4 24 | $-17.2M | $15.6M | ||
| Q3 24 | $15.0M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $260.0K | — |
自由现金流率HNSTPBYI
| Q4 25 | 20.5% | 19.1% | ||
| Q3 25 | -0.7% | 17.7% | ||
| Q2 25 | -0.9% | 26.8% | ||
| Q1 25 | -3.1% | 7.7% | ||
| Q4 24 | -17.2% | 26.4% | ||
| Q3 24 | 15.1% | 13.7% | ||
| Q2 24 | 3.1% | 2.1% | ||
| Q1 24 | 0.3% | — |
资本支出强度HNSTPBYI
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率HNSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | -0.66× | 1.10× | ||
| Q2 25 | -0.19× | 2.41× | ||
| Q1 25 | -0.90× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 91.42× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
